Search hospitals > New York > Bronx

James J Peters VA Medical Center

Claim this profile
Bronx, New York 10468
Global Leader in Spinal Cord Injury
Global Leader in Wounds and Injuries
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
Conducts research for Lung Cancer
219 reported clinical trials
32 medical researchers
Photo of James J Peters VA Medical Center in BronxPhoto of James J Peters VA Medical Center in BronxPhoto of James J Peters VA Medical Center in Bronx

Summary

James J Peters VA Medical Center is a medical facility located in Bronx, New York. This center is recognized for care of Spinal Cord Injury, Wounds and Injuries, Non-Small Cell Lung Cancer, Cancer, Lung Cancer and other specialties. James J Peters VA Medical Center is involved with conducting 219 clinical trials across 253 conditions. There are 32 research doctors associated with this hospital, such as Gary Schwartz, MD, Susan E. Bates, Jill M Wecht, EdD, and Yeun-Hee A. Park.

Area of expertise

1Spinal Cord Injury
Global Leader
James J Peters VA Medical Center has run 68 trials for Spinal Cord Injury. Some of their research focus areas include:
C1
C2
C3
2Wounds And Injuries
Global Leader
James J Peters VA Medical Center has run 20 trials for Wounds and Injuries.

Top PIs

Clinical Trials running at James J Peters VA Medical Center

Prostate Cancer
Non-Small Cell Lung Cancer
Spinal Cord Injury
Lung Cancer
Coronavirus
Depression
Suicide
Orthostatic Hypotension
Cancer
Osteoarthritis
Image of trial facility.

Pembrolizumab

for Prostate Cancer

The primary objective is to assess the activity and efficacy of pembrolizumab, a checkpoint inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC) characterized by either mismatch repair deficiency (dMMR) or biallelic inactivation of CDK12 (CDK12-/-). The secondary objectives involve determining the frequency with which dMMR and CDK12-/- occur in this patient population, as well as the effects of pembrolizumab on various clinical endpoints (time to PSA progression, maximal PSA response, time to initiation of alternative anti-neoplastic therapy, time to radiographic progression, overall survival, and safety and tolerability). Lastly, the study will compare the pre-treatment and at-progression metastatic tumor biopsies to investigate the molecular correlates of resistance and sensitivity to pembrolizumab via RNA-sequencing, exome-sequencing, selected protein analyses, and multiplexed immunofluorescence.
Recruiting2 awards Phase 23 criteria
Image of trial facility.

Copper PET Imaging

for Recurrent Prostate Cancer

This is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I\&T injection for PET/CT imaging in patients with recurrent prostate cancer after radical prostatectomy or radiation therapy.
Recruiting2 awards Phase 33 criteria
Image of trial facility.

Standard Therapy + Surgery/Radiation

for Prostate Cancer

This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at James J Peters VA Medical Center?
James J Peters VA Medical Center is a medical facility located in Bronx, New York. This center is recognized for care of Spinal Cord Injury, Wounds and Injuries, Non-Small Cell Lung Cancer, Cancer, Lung Cancer and other specialties. James J Peters VA Medical Center is involved with conducting 219 clinical trials across 253 conditions. There are 32 research doctors associated with this hospital, such as Gary Schwartz, MD, Susan E. Bates, Jill M Wecht, EdD, and Yeun-Hee A. Park.